• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Aegon gets “buy” rating from BofA, shares up

by November 29, 2024
written by November 29, 2024

Investing.com — Shares of Aegon (AS:AEGN) rose over 2% on Friday following an upgrade from BofA Securities, revising its rating on the company to “buy” and increased its price target to €7. 

Analysts at BofA flag Aegon’s efforts in de-risking its business and stabilizing its earnings. The company’s pledge to return excess cash over time was noted as a pivotal factor, presenting an opportunity for re-rating. 

The analysts also emphasized Aegon’s unique advantage as a beneficiary of macroeconomic conditions in the U.S., particularly given its earnings’ heavy reliance on the U.S. dollar and its operations’ sensitivity to equity markets.

Aegon is expected to benefit from the current economic environment, characterized by sustained higher interest rates in the U.S., which support sales, reinvestment rates, and capital. 

BofA analysts project a 4-6% increase in operating capital generation and a reduced cost of equity to 13%, contributing to the revised price target. These developments imply a potential total return of 25% from the current share price.

Additionally, Aegon’s capital return strategy includes initiating a €150 million share buyback program and reducing its holding cash pile from €1.7 billion to €1 billion over time. 

BofA anticipates additional buybacks totaling €600 million in 2025 and €500 million in 2026, cumulatively amounting to 37% of the company’s market capitalization within three years.

Despite the positive outlook, BofA analysts acknowledged ongoing challenges for Aegon, particularly in demonstrating growth and operational improvements. 

Success in enhancing asset management profitability and solidifying Transamerica’s market position in life insurance and retirement services could further strengthen investor sentiment and reduce the company’s cost of equity.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
JPMorgan is bullish on European hotel stocks, upgrades 2 names
next post
RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025
    • 5 new Uber features you should know — including a way to avoid surge pricing

      May 15, 2025
    • American Eagle shares plunge 17% after it withdraws guidance, writes off $75 million in inventory

      May 14, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (462)
    • Stock (6,426)

    Latest News

    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion
    • YouTube will stream NFL Week 1 game in Brazil for free

    Popular News

    • European stocks tumble after Fed’s hawkish signal
    • Warner Bros Discovery, NBA settle legal battle over broadcast rights, WSJ reports

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy